Holen Sie sich die Stockscreener-App
40.39
1.75%
-0.72
Finanzdaten der Protagonist Therapeutics Inc-Aktie (PTGX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
324.92%
254.95
|
60.00 | - | - | - |
Operating Expenses
|
31.64%
48.64
|
36.95 | 38.33 | 42.35 | 36.02 |
| Benefits Costs and Expenses |
44.29
|
- | - | - | - |
| Costs And Expenses |
44.29
|
- | - | - | - |
| Operating Income/Loss |
795.09%
206.31
|
23.05 | -38.33 | -42.35 | -36.02 |
| Income/Loss From Continuing Operations Before Tax |
670.68%
210.67
|
27.34 | -34.10 | -38.46 | -33.73 |
| Income Tax Expense/Benefit |
3.326
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
658.51%
207.34
|
27.34 | -34.10 | -38.46 | -33.73 |
|
Net Income/Loss
|
658.51%
207.34
|
27.34 | -34.10 | -38.46 | -33.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4,884%
60.86
|
1.221 | 59.18 | 56.78 | 50.57 |
| Diluted Average Shares |
5,108%
63.60
|
1.221 | 59.18 | 56.78 | 50.57 |
| Basic Earnings Per Share |
555.77%
3.41
|
0.52 | -0.58 | -0.68 | -0.67 |
| Diluted Earnings Per Share |
526.92%
3.26
|
0.52 | -0.58 | -0.68 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):